Low mortality from COVID-19 infection in patients with B-cell lymphoma after bispecific CD20xCD3 therapy.

Autor: Kyvsgaard ER; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.; Phase 1 Unit, Rigshospitalet, Copenhagen, Denmark.; Biotech Research and Innovation Center (BRIC), University of Copenhagen, Copenhagen, Denmark., Riley C; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.; Phase 1 Unit, Rigshospitalet, Copenhagen, Denmark., Clausen MR; Department of Hematology, Vejle University Hospital, Vejle, Denmark., Harsløf M; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.; Phase 1 Unit, Rigshospitalet, Copenhagen, Denmark., Heftdal LD; Viro-immunology Research Unit, Department of Infectious Diseases, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark., Niemann CU; Department of Hematology, Rigshospitalet, Copenhagen, Denmark., Grønbaek K; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.; Phase 1 Unit, Rigshospitalet, Copenhagen, Denmark., Hutchings M; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.; Phase 1 Unit, Rigshospitalet, Copenhagen, Denmark., Husby S; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.; Phase 1 Unit, Rigshospitalet, Copenhagen, Denmark.; Biotech Research and Innovation Center (BRIC), University of Copenhagen, Copenhagen, Denmark.
Jazyk: angličtina
Zdroj: British journal of haematology [Br J Haematol] 2024 Jan; Vol. 204 (1), pp. 356-360. Date of Electronic Publication: 2023 Oct 13.
DOI: 10.1111/bjh.19156
Databáze: MEDLINE
Externí odkaz: